Lucas Hahn

Lucas Hahn

InvestorPlace Contributor

Lucas Hahn graduated from the University of California, Irvine in June 2013 with bachelor’s degrees in international studies and political science. A longtime passion of his has been the financial markets, particularly with regards to China. He currently teaches English to children in Taiwan and is learning Mandarin.

Recent Articles

Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Risky

By Lucas Hahn, InvestorPlace Contributor

TEVA stock is down 40% over the past year, and trades at low multiples. Is this a good time to buy Teva Pharmaceuticals stock?

4 Reasons Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Terrifying

By Lucas Hahn, InvestorPlace Contributor

It's good to be a contrarian, but not a knee-jerk contrarian with VRX stock. The market is probably right about Valeant now.

Will Snap Lose the War With Facebook?

By Lucas Hahn, InvestorPlace Contributor

Facebook's (FB) tactic against Snap (SNAP) is a twist on a classic: "If you can't buy 'em, join 'em." SNAP stock holders should be scared.

The Strength of Alibaba Group Holding Ltd (BABA) Stock’s Subsidiary Ant Financial

By Lucas Hahn, InvestorPlace Contributor

Alibaba's Ant Financial is speeding up its global expansion, with purchases in the U.S., the Philippines and Korea.

Why the Next Frontier for Amazon.com, Inc. (AMZN) Stock Could Be Finance

By Lucas Hahn, InvestorPlace Contributor

AMZN does not fear low-margin industries, making Amazon stock the most likely tech stock to move toward finance.

Load More